Surmodics, Inc.
General ticker "SRDX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $462.9M (TTM average)
Surmodics, Inc. follows the US Stock Market performance with the rate: 18.3%.
Estimated limits based on current volatility of 0.2%: low 42.93$, high 43.08$
Factors to consider:
- Total employees count: 389 (+3.5%) as of 2024
- Top business risk factors: Labor/talent shortage/retention, Cybersecurity threats, Economic downturns and volatility, Production inefficiency, Regulatory and compliance
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [26.19$, 45.92$]
- 2025-09-30 to 2026-09-30 estimated range: [25.13$, 44.70$]
Financial Metrics affecting the SRDX estimates:
- Negative: with PPE of -101.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of 0.04 <= 0.33
- Positive: Industry inventory ratio change (median), % of -0.92 <= -0.15
- Positive: Investing cash flow per share per price, % of -0.53 > -0.66
- Positive: Shareholder equity ratio, % of 66.59 > 63.39
- Positive: Interest expense per share per price, % of 0.64 <= 0.79
Short-term SRDX quotes
Long-term SRDX plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $99.95MM | $132.58MM | $126.08MM |
| Operating Expenses | $122.05MM | $127.43MM | $131.72MM |
| Operating Income | $-22.10MM | $5.15MM | $-5.64MM |
| Non-Operating Income | $-0.40MM | $-2.66MM | $-1.86MM |
| Interest Expense | $0.60MM | $3.49MM | $3.54MM |
| R&D Expense | $50.61MM | $46.59MM | $38.36MM |
| Income(Loss) | $-22.49MM | $2.49MM | $-7.51MM |
| Taxes | $4.78MM | $4.02MM | $4.04MM |
| Profit(Loss)* | $-27.27MM | $-1.54MM | $-11.54MM |
| Stockholders Equity | $108.39MM | $119.91MM | $118.90MM |
| Inventory | $11.82MM | $14.84MM | $15.17MM |
| Assets | $158.36MM | $185.73MM | $178.56MM |
| Operating Cash Flow | $-17.22MM | $10.51MM | $0.25MM |
| Capital expenditure | $3.37MM | $2.92MM | $3.49MM |
| Investing Cash Flow | $6.23MM | $-6.82MM | $-2.94MM |
| Financing Cash Flow | $-0.38MM | $18.41MM | $-2.95MM |
| Earnings Per Share** | $-1.96 | $-0.11 | $-0.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.